Home > Healthcare > Medical Services > Diagnostic Services > Healthcare Regulatory Affairs Outsourcing Market

Healthcare Regulatory Affairs Outsourcing Market Share

Report ID: GMI8287
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Healthcare Regulatory Affairs Outsourcing Market Share

The healthcare regulatory affairs outsourcing industry is fragmented in nature, with various large multinationals and small and mid-sized companies competing in the industry. Providers in this space focus on delivering expertise in navigating complex regulatory frameworks, ensuring compliance, and facilitating smooth interactions with regulatory authorities. Their commitment to efficient and cost-effective regulatory solutions positions them as indispensable partners for companies seeking streamlined approval processes and regulatory compliance. Some of the leading industry players including Thermo Fisher Scientific Inc, Genpact, ICON plc, among others have a substantial presence in the market.

Healthcare Regulatory Affairs Outsourcing Market Companies

Some of the eminent market participants operating in the healthcare regulatory affairs outsourcing industry include:

Accell Clinical Research, LLC
Charles River Laboratories
Clinilabs, Inc.
Freyr
Genpact
ICON plc
Labcorp Drug Development
PAREXEL International Corporation
ProPharma Group
Proventa International
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of healthcare regulatory affairs outsourcing reached USD 7.1 billion in 2023 and is set to cross USD 14.8 billion by 2032, attributed to the growing need to comply with regulatory requirements, and surging demand for faster approval processes for breakthrough drugs and devices.

The product registration & clinical trial segment is anticipated to witness a CAGR of 8.5% through 2032, owing to its role in guiding companies through the complexities of gaining regulatory approvals for new medical products.

North America market accounted for USD 2.8 billion revenue in 2023, driven by well-established medical infrastructure and stringent regulatory environment governing healthcare product.

Accell Clinical Research, LLC, Charles River Laboratories, Clinilabs, Inc., Freyr, Genpact, ICON plc, Labcorp Drug Development, PAREXEL International Corporation, ProPharma Group, Proventa International are some of the major industry contenders.